Publications by authors named "Hussamon Prasartkaew"
Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience.
Tasma Harindhanavudhi Chatvara Areevut Taninee Sahakitrungruang Thipaporn Tharavanij Pongtorn Kietdumrongwong Hussamon Prasartkaew
J Diabetes Investig
August 2022
Background: The coronavirus disease (COVID-19) outbreak in Bangkok led to a shortage of hospital capacity, and a home isolation system was set up. We described the process of diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection.
Methods: A retrospective chart review of glucose values, insulin and corticosteroids use, and outcomes was performed.
Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.
Yotsapon Thewjitcharoen Hussamon Prasartkaew Phatharaporn Tongsumrit Saruda Wongjom Chatnapa Boonchoo
Diabetes Metab Syndr Obes
November 2020
Article Synopsis
- Insulin-induced lipodystrophy is a common issue in insulin-treated diabetes patients in Thailand, particularly among those with longer durations of insulin use; it affects about 37.3% of patients studied.
- The study involved 400 patients and found that long-standing Type 1 diabetes (T1DM) patients had the highest prevalence of lipohypertrophy (LH) at 57.5%, with incorrect injection site rotation significantly increasing the risk.
- Lipodystrophy increases the risk of unexplained hypoglycemia seven-fold, highlighting the need for better awareness and education regarding proper injection techniques among patients.